Examination of polymorphic glutathione S-transferase (GST) genes, tobacco smoking and prostate cancer risk among Men of African Descent: A case-control study

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Lavender, Nicole A ^a,b   Benford, Marnita L ^a,b   VanCleave, Tiva T ^a,b   Brock, Guy N ^a,b,c,d   Kittles, Rick A ^e   Moore, Jason H ^f   Hein, David W ^a,b,d   Kidd, La Creis R ^a,b,c  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^c School of Public Health Information Sciences (SPHIS)   (United States)

^d Delia B Baxter Biomedical Research Building   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; VALINE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICA; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; ENTROPY; GENE INTERACTION; GENE LOCUS; GENETIC ALGORITHM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PROSTATE CANCER; SMOKING; AFRICAN AMERICAN; BLOOD; GENETIC PREDISPOSITION; GENETICS; POLYMERASE CHAIN REACTION; PROSTATE TUMOR; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; SMOKING;

EID: 71049161271     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-397     Document Type: Article

References (57)

1. American Cancer Society Cancer Facts & Figures 2009. 2009,
2. Mudashiru AS, Blessing E, Olapade-Olaopa EO. Update on prostate cancer in black men. J Men's Health & Gender 2007, 4:456-463.
3. Powell IJ. Epidemiology and pathophysiology of prostate cancer in African-American men. J Urol 2007, 177:444-449. 10.1016/j.juro.2006.09.024, 17222606.
4. Hsing AW, Chokkalingam AP. Prostate cancer epidemiology. Front Biosci 2006, 11:1388-1413. 10.2741/1891, 16368524.
5. Agalliu I, Langeberg WJ, Lampe JW, Salinas CA, Stanford JL. Glutathione S-transferase M1, T1, and P1 polymorphisms and prostate cancer risk in middle-aged men. Prostate 2006, 66:146-156. 10.1002/pros.20305, 16173036.
6. Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000, 61:154-166. 10.1159/000028396, 10971201.
7. Mannervik B, Alin P, Guthenberg C, Jensson H, Tahir MK, Warholm M. Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc Natl Acad Sci USA 1985, 82:7202-7206. 10.1073/pnas.82.21.7202, 390817, 3864155.
8. Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 1997, 18:1285-1289. 10.1093/carcin/18.7.1285, 9230269.
9. Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 1997, 272:10004-10012. 10.1074/jbc.272.15.10004, 9092542.
10. Sundberg K, Johansson AS, Stenberg G, Widersten M, Seidel A, Mannervik B. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 1998, 19:433-436. 10.1093/carcin/19.3.433, 9525277.
11. Ntais C, Polycarpou A, Ioannidis JP. Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2005, 14:176-181.
12. Mo Z, Gao Y, Cao Y, Gao F, Jian L. An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review. Prostate 2009, 69:662-688. 10.1002/pros.20907, 19143011.
13. Coughlin SS, Hall IJ. A review of genetic polymorphisms and prostate cancer risk. Ann Epidemiol 2002, 12:182-196. 10.1016/S1047-2797(01)00310-6, 11897176.
14. Lee E, Huang Y, Zhao B, Seow-Choen F, Balakrishnan A, Chan SH. Genetic polymorphism of conjugating enzymes and cancer risk: GSTM1, GSTT1, NAT1 and NAT2. J Toxicol Sci 1998, 23(Suppl 2):140-142.
15. Sreelekha TT, Ramadas K, Pandey M, Thomas G, Nalinakumari KR, Pillai MR. Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol 2001, 37:593-598. 10.1016/S1368-8375(01)00028-8, 11564581.
16. Katoh T, Inatomi H, Kim H, Yang M, Matsumoto T, Kawamoto T. Effects of glutathione S-transferase (GST) M1 and GSTT1 genotypes on urothelial cancer risk. Cancer Lett 1998, 132:147-152. 10.1016/S0304-3835(98)00183-9, 10397466.
17. Salagovic J, Kalina I, Stubna J, Habalova V, Hrivnak M, Valansky L. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers. Neoplasma 1998, 45:312-317.
18. Nakazato H, Suzuki K, Matsui H, Koike H, Okugi H, Ohtake N. Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population. Anticancer Res 2003, 23:2897-2902.
19. Murata M, Watanabe M, Yamanaka M, Kubota Y, Ito H, Nagao M. Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett 2001, 165:171-177. 10.1016/S0304-3835(01)00398-6, 11275366.
20. Steinhoff C, Franke KH, Golka K, Thier R, Romer HC, Rotzel C. Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol 2000, 74:521-526. 10.1007/s002040000161, 11131031.
21. Komiya Y, Tsukino H, Nakao H, Kuroda Y, Imai H, Katoh T. Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population. J Cancer Res Clin Oncol 2005, 131:238-242. 10.1007/s00432-004-0634-z, 15616829.
22. Autrup JL, Thomassen LH, Olsen JH, Wolf H, Autrup H. Glutathione S-transferases as risk factors in prostate cancer. Eur J Cancer Prev 1999, 8:525-532. 10.1097/00008469-199912000-00008, 10643942.
23. Wadelius M, Autrup JL, Stubbins MJ, Andersson SO, Johansson JE, Wadelius C. Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer. Pharmacogenetics 1999, 9:333-340. 10.1097/00008571-199906000-00008, 10471065.
24. Gsur A, Haidinger G, Hinteregger S, Bernhofer G, Schatzl G, Madersbacher S. Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk. Int J Cancer 2001, 95:152-155. 10.1002/1097-0215(20010520)95:3<152::AID-IJC1026>3.0.CO;2-S, 11307147.
25. Beer TM, Evans AJ, Hough KM, Lowe BA, McWilliams JE, Henner WD. Polymorphisms of GSTP1 and related genes and prostate cancer risk. Prostate Cancer Prostatic Dis 2002, 5:22-27. 10.1038/sj.pcan.4500549, 15195126.
26. Mallick S, Romana M, Blanchet P, Multigner L. GSTM1 and GSTT1 polymorphisms and the risk of prostate cancer in a Caribbean population of African descent. Urology 2007, 69:1165-1169. 10.1016/j.urology.2007.02.039, 17572208.
27. Nock NL, Liu X, Cicek MS, Li L, Macarie F, Rybicki BA. Polymorphisms in polycyclic aromatic hydrocarbon metabolism and conjugation genes, interactions with smoking and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2006, 15:756-761. 10.1158/1055-9965.EPI-05-0826, 16614120.
28. Giri VN, Egleston B, Ruth K, Uzzo RG, Chen DY, Buyyounouski M. Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men. Cancer Prev Res (Phila Pa) 2009, 2:244-250.
29. Brasch-Andersen C, Christiansen L, Tan Q, Haagerup A, Vestbo J, Kruse TA. Possible gene dosage effect of glutathione-S-transferases on atopic asthma: using real-time PCR for quantification of GSTM1 and GSTT1 gene copy numbers. Hum Mutat 2004, 24:208-214. 10.1002/humu.20074, 15300848.
30. Packer BR, Yeager M, Burdett L, Welch R, Beerman M, Qi L. SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 2006, 34:D617-D621. 10.1093/nar/gkj151, 1347513, 16381944.
31. Covault J, Abreu C, Kranzler H, Oncken C. Quantitative real-time PCR for gene dosage determinations in microdeletion genotypes. Biotechniques 2003, 35:594-6. 598.
32. Tian C, Hinds DA, Shigeta R, Kittles R, Ballinger DG, Seldin MF. A genomewide single-nucleotide-polymorphism panel with high ancestry information for African American admixture mapping. Am J Hum Genet 2006, 79:640-649. 10.1086/507954, 1592561, 16960800.
33. Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003, 19:376-382. 10.1093/bioinformatics/btf869, 12584123.
34. Ritchie MD, Hahn LW, Moore JH. Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 2003, 24:150-157. 10.1002/gepi.10218, 12548676.
35. Hahn LW, Moore JH. Ideal discrimination of discrete clinical endpoints using multilocus genotypes. In Silico Biol 2004, 4:183-194.
36. Jakulin A, Bratko I. Analyzing attribute depedencies. 2003, 229-240. Cavtat, Croatia.: Springer-Verlag, PKDD, Lavrac N, Gamberger D, Blockeel H, Todorovski L.
37. Demosar J, Zupan B. Orange: From Experimental Machine Learning to Interactive Data Mining, White Paper 2004,
38. Andrew AS, Nelson HH, Kelsey KT, Moore JH, Meng AC, Casella DP. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking, and bladder cancer susceptibility. Carcinogenesis 2006, 27:1030-1037. 10.1093/carcin/bgi284, 16311243.
39. Jakulin A, Bratko I, Smrike D, Demsar J, Zupan B. Attribute interactions in medical data analysis. Protarus: Cyprus 2003, 229-238.
40. National Center for Biotechnology Information (NCBI) website. 2007, , http://www.ncbi.nlm.nih.gov
41. Nock NL, Liu X, Cicek MS, Li L, Macarie F, Rybicki BA. Polymorphisms in polycyclic aromatic hydrocarbon metabolism and conjugation genes, interactions with smoking and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2006, 15:756-761. 10.1158/1055-9965.EPI-05-0826, 16614120.
42. Sikka SC. Role of oxidative stress response elements and antioxidants in prostate cancer pathobiology and chemoprevention--a mechanistic approach. Curr Med Chem 2003, 10:2679-2692. 10.2174/0929867033456341, 14529458.
43. Kelada SN, Kardia SL, Walker AH, Wein AJ, Malkowicz SB, Rebbeck TR. The glutathione S-transferase-mu and -theta genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking. Cancer Epidemiol Biomarkers Prev 2000, 9:1329-1334.
44. Fleshner NE, Klotz LH. Diet, androgens, oxidative stress and prostate cancer susceptibility. Cancer Metastasis Rev 1998, 17:325-330. 10.1023/A:1006118628183, 10453275.
45. Abate-Shen C, Shen MM. Molecular genetics of prostate cancer. Genes Dev 2000, 14:2410-2434. 10.1101/gad.819500, 11018010.
46. Choi JY, Neuhouser ML, Barnett M, Hudson M, Kristal AR, Thornquist M. Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers. Cancer Epidemiol Biomarkers Prev 2007, 16:1115-1120. 10.1158/1055-9965.EPI-07-0040, 17548672.
47. Waris G, Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog 2006, 5:14. 10.1186/1477-3163-5-14, 1479806, 16689993.
48. Miyake H, Hara I, Kamidono S, Eto H. Oxidative DNA damage in patients with prostate cancer and its response to treatment. J Urol 2004, 171:1533-1536. 10.1097/01.ju.0000116617.32728.ca, 15017214.
49. Medeiros R, Vasconcelos A, Costa S, Pinto D, Ferreira P, Lobo F. Metabolic susceptibility genes and prostate cancer risk in a southern European population: the role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms. Prostate 2004, 58:414-420. 10.1002/pros.10348, 14968442.
50. Kidd LR, Woodson K, Taylor PR, Albanes D, Virtamo J, Tangrea JA. Polymorphisms in glutathione-S-transferase genes (GST-M1, GST-T1 and GST-P1) and susceptibility to prostate cancer among male smokers of the ATBC cancer prevention study. Eur J Cancer Prev 2003, 12:317-320. 10.1097/00008469-200308000-00012, 12883385.
51. McCarty KM, Santella RM, Steck SE, Cleveland RJ, Ahn J, Ambrosone CB. PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk. Environ Health Perspect 2009, 117:552-558. 2679598, 19440493.
52. Mir O, Alexandre J, Tran A, Durand JP, Pons G, Treluyer JM. Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity. Ann Oncol 2009, 20:736-740. 10.1093/annonc/mdn698, 19223573.
53. Sreeja L, Syamala V, Hariharan S, Syamala VS, Raveendran PB, Sivanandan CD. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients. J Exp Ther Oncol 2008, 7:73-85.
54. Rybicki BA, Neslund-Dudas C, Nock NL, Schultz LR, Eklund L, Rosbolt J. Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphism. Cancer Detect Prev 2006, 30:412-422. 10.1016/j.cdp.2006.09.004, 1769317, 17067754.
55. Loeb S, Catalona WJ. What is the prognostic impact of positive surgical margins in surgically treated prostate cancer?. Nat Clin Pract Urol 2006, 3:418-419. 10.1038/ncpuro0549, 16902516.
56. Shriver MD, Kittles RA. Genetic ancestry and the search for personalized genetic histories. Nat Rev Genet 2004, 5:611-618. 10.1038/nrg1405, 15266343.
57. Kittles RA, Chen W, Panguluri RK, Ahaghotu C, Jackson A, Adebamowo CA. CYP3A4-V and prostate cancer in African Americans: causal or confounding association because of population stratification?. Hum Genet 2002, 110:553-560. 10.1007/s00439-002-0731-5, 12107441.